Bipolar Androgen Therapy + Carboplatin in mCRPC

NCT03522064 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Castration-resistant Prostate Cancer
Homologous Recombination Deficiency

Interventions

DRUG: Testosterone Enanthate 100 MG/ML Injectable Solution
DRUG: Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5

Sponsor

St Vincent's Hospital, Sydney